Remus Pharmaceuticals Quarterly Results for Trading Insights
REMUS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹38 Cr
QMarch 2025
Remus Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹625 Cr in March 2025 (+0.0% vs March 2025, +189.4% vs March 2024)
- Net Profit of ₹38 Cr in March 2025 (+0.0% vs March 2025, +58.3% vs March 2024)
- EBITDA of ₹51 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 7.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹65.21 in March 2025 (+0.0% vs March 2025)
Remus Pharmaceuticals Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | QoQ | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 625 | 216 | - | - |
| Net Profit (₹ Cr) | 0 | 38 | 24 | - | - |
| EBITDA (₹ Cr) | 0 | 51 | 32 | - | - |
| EPS (₹) | 0.00 | 65.21 | 42.97 | - | - |
| Operating Margin (%) | 0.0% | 7.0% | 14.0% | - | - |
Remus Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Remus Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Remus Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Remus Pharmaceuticals
Additional stock information and data for REMUS
Revenue Trend (₹ Cr)
March 2024
216
March 2025
625
2026
0
Net Profit Trend (₹ Cr)
March 2024
24
March 2025
38
2026
0
Operating Margin Trend (%)
March 2024
14.0%
March 2025
7.0%
2026
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Remus Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores